View Post

Cancer vaccines enter clinical trials

In In The News, Uncategorized by Barbara Jacoby

By Blythe Bernhard From: stltoday.com Is the best treatment for cancer already inside of us? Research is underway at Washington University to test a new approach to cancer treatment. Beyond traditional therapies like surgery, chemotherapy and radiation, scientists want to know if the human body’s own immune system can attack tumors. They’re testing personalized vaccines designed to target deadly cancer …

View Post

Breast Cancer: New Test Determines If Disease Will Spread To Brain

In In The News, Uncategorized by Barbara Jacoby

By: Kathleen Lees From: scienceworldreport.com A new test may help identify if particularly aggressive forms of breast cancer are at risk of spreading to the brain. The findings are published in the journal npj Breast Cancer. Findings revealed that participants who tested positive for the gene known as alpha beta (αB)-crystallin were up to three times more likely to have …

View Post

EU Recommends Approval of Roche’s Pre-Surgery Breast Cancer Treatment

In In The News, Uncategorized by Barbara Jacoby

From: dddmag.com Roche announced that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approves the use of Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy for the neoadjuvant treatment (use before surgery) of adult patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrence. The EU filing was …

View Post

DDT in Pregnancy May Raise Breast Cancer Rates in Daughters

In In The News, Uncategorized by Barbara Jacoby

By: Maggie Fox and Judy Silverman From: nbcnews.com Women whose mothers had higher levels of DDT in their blood while pregnant were nearly four times more likely to develop breast cancer as adults, a new study finds. The report provides one of the strongest links yet between exposure to DDT – still widely used globally – and cancer. It’s especially …

Email Verification

In Uncategorized by Barbara Jacoby

[email_verification] Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. http://LetLifeHappen.com

View Post

Blog Post Ad Placement

In Uncategorized by Barbara Jacoby

Lorem ipsum dolor sit amet, mollis tibique mentitum te sed, cu vel veritus assentior. Nisl perpetua scriptorem no ius, ceteros delicata ad pri. No mea vidisse singulis signiferumque, ullum possim adversarium cu eum, ea nostro reprehendunt nam. Quo wisi tritani maiorum ei. Eruditi dolorem principes no mei, pro vocibus voluptua suscipiantur at. Ex eius debitis eam, ad vix duis latine …

View Post

An App for That: Game-Changer for Breast Cancer Patients

In In The News, Uncategorized by Barbara Jacoby

BY: Judith A. Salerno President and CEO, Susan G. Komen From: .huffingtonpost.com One of the most remarkable qualities of the breast cancer community is its willingness to help others who are facing the disease today or might in the future. Millions of people in our community now have the opportunity to do that, and in my view, it’s a game-changer. …

View Post

What you can do to cut your cancer risk

In In The News, Uncategorized by Barbara Jacoby

By Michele Munz From: freep.com Cancer can be seen as striking haphazardly, but research over the past 40 years shows that lifestyle factors play a huge role in cancer incidence and mortality. Dr. Graham Colditz, an internationally recognized disease-prevention expert at Siteman Cancer Center at Barnes-Jewish Hospital, has put together a list of behaviors that greatly reduce overall cancer risk. …

View Post

Trial finds cancer drug can block key signal in cancer growth and drug resistance

In In The News, Uncategorized by Barbara Jacoby

From: http://medicalxpress.com The first clinical trial of an experimental drug, called pictilisib, found the safety profile to be manageable in cancer patients at doses that successfully blocked the PI3 kinase pathway, which is hijacked in many different tumour types. The study, led by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, has cleared …